CD44 and cancer: Among the most studied receptor proteins are CD44 and receptor for hyaluronan-mediated motility (RHAMM), as they participate in inflammation and cancer motility, migration and metastasis (Slevin et al., 2007; Lokeshwar et al., 2014; Tolg et al., 2014; Misra et al., 2015).